berberine/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases total cholesterol (TC)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×2“Berberine led to significant declines in total cholesterol, low-density lipoprotein cholesterol, fasting serum insulin, and insulin resistance(all p<0.05) compared with placebo.”
Quoted verbatim from The effect of berberine adjunctive treatment on glycolipid metabolism in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial.. - Study
- RCT
- Duration
- 8 weeks
- Dose
- berberine 900 mg/day
- Population
- patients with schizophrenia, berberine given as adjunctive treatment
The effect of berberine adjunctive treatment on glycolipid metabolism in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial.2021PMID:33812218Permalink
Keep reading
- Everything the graph holds on berberine
- Every compound studied against Total cholesterol (TC)
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M2RD904F74WNSGXYT9E1YPJK